CP and cancer: To validate these findings across other therapeutically relevant cell types, we compared the gene signatures associated with ploidy obtained from mesenchymal stem cells (MSC) and cancer cells to the ploidy-related transcriptomic alterations observed in CP and in the young CARD of patients with HPLV compared to healthy individuals [36].